GO:0045104 intermediate filament cytoskeleton organization: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045104 intermediate filament cytoskeleton organization describes the cellular process that assembles, arranges, and disassembles intermediate filament (IF) networks and their associated proteins.
• IFs are a major cytoskeletal system alongside actin microfilaments and microtubules, forming a complex interacting meshwork that maintains cell shape and mechanical integrity.
• IF organization is dynamic, involving subunit exchange, filament assembly, and network remodeling rather than simple static polymerization.
• Cell-type-specific IF proteins include keratins in epithelia, vimentin in mesenchymal cells, desmin in muscle, GFAP in glia, and neurofilaments in neurons.
• Disrupted IF organization is linked to human disease, including neurodegeneration, skin blistering disorders, and cancer-associated changes in vimentin expression.
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of IF genes in relevant cell types.
Description
Intermediate filament cytoskeleton organization (GO:0045104) is the biological process that carries out the assembly, arrangement, and disassembly of cytoskeletal structures composed of intermediate filaments (IFs) and their associated proteins. IFs are one of the three principal cytoskeletal systems in metazoan cells, together with actin filaments and microtubules, and they form a complex interacting meshwork that contributes to cell shape, mechanical resilience, and tissue integrity. Unlike actin and microtubules, IFs are encoded by a large and cell-type-specific gene family, and their organization is dynamically regulated during differentiation, migration, and stress responses. Understanding GO:0045104 is important because IF networks are not passive scaffolds. They participate in mechanotransduction, organelle positioning, and signaling, and their disruption is associated with a wide range of human pathologies, including neurodegenerative diseases, skin fragility disorders, and cancer progression. For example, neurofilament organization is critical for axonal caliber and function, and abnormal neurofilament accumulation is a hallmark of several neurodegenerative conditions. In mesenchymal cells, vimentin IFs act as structural and mechanical coordinators that influence cell migration and matrix interactions. This article summarizes the definition, molecular components, regulatory features, disease links, and research methods relevant to GO:0045104. It is intended for researchers who need a concise, citable overview of intermediate filament cytoskeleton organization and who may wish to model it using CRISPR-based approaches.
intermediate filament cytoskeleton organization At A Glance
| GO ID | GO:0045104 |
|---|---|
| GO term | intermediate filament cytoskeleton organization |
| Ontology | biological_process |
| Synonym | intermediate filament cytoskeleton organisation; intermediate filament cytoskeleton organization and biogenesis |
| Major function | Assembly, arrangement, and disassembly of intermediate filament networks and associated proteins |
| Cellular context | Cytoskeleton; intermediate filament system |
| Key protein families | Keratins, vimentin, desmin, GFAP, neurofilaments, lamins, and IF-associated proteins |
| Representative processes | Filament assembly, network remodeling, mechanical support, cell shape maintenance |
| Disease relevance | Neurodegeneration, skin disorders, cancer, and other IF-related pathologies |
What Is GO:0045104?
GO:0045104 intermediate filament cytoskeleton organization is defined as a process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising intermediate filaments and their associated proteins. In simpler terms, it covers how cells build, position, remodel, and take apart intermediate filament networks, including the proteins that bind to and regulate those networks.
Why Is intermediate filament cytoskeleton organization Important in Cell Biology?
Intermediate filament cytoskeleton organization is important because IF networks provide essential mechanical and structural support to cells and tissues, and their dynamic reorganization is required for normal development, differentiation, and stress responses. Because IF proteins are cell-type-specific and highly regulated, defects in their organization can cause or contribute to human disease, making GO:0045104 a key process for both basic cell biology and translational research.
• Maintains cell shape and mechanical integrity through IF networks.
• Enables dynamic remodeling of the cytoskeleton during differentiation and migration.
• Supports axonal structure and function via neurofilament organization.
• Contributes to glial and neuronal cell architecture through GFAP and neurofilaments.
• Regulates mesenchymal cell mechanics and migration via vimentin IFs.
• Is linked to skin blistering disorders caused by keratin mutations.
• Is implicated in cancer progression through altered vimentin expression and organization.
• Provides a target for CRISPR-based modeling of IF-related diseases.
• Helps explain how cells respond to mechanical stress and injury.
• Offers biomarkers and therapeutic targets in neurodegeneration and oncology.
What Happens During intermediate filament cytoskeleton organization?
Filament subunit synthesis and availability
In simple terms: Cells first make the intermediate filament proteins that will be used to build the network.
Intermediate filament organization begins with the expression and availability of IF proteins, which are encoded by a large family of cell-type-specific genes. These proteins include keratins in epithelial cells, vimentin in mesenchymal cells, desmin in muscle, GFAP in glial cells, and neurofilament proteins in neurons. The abundance and ratio of these subunits influence the composition and properties of the resulting IF network.
Assembly of intermediate filament subunits into filaments
In simple terms: IF proteins come together to form long, rope-like filaments.
IF proteins assemble into filaments through a conserved structural mechanism involving coiled-coil dimer formation and higher-order lateral association. This assembly process is dynamic and can involve subunit exchange and reorganization rather than a simple irreversible polymerization. The resulting filaments form networks that extend throughout the cytoplasm and, in some cases, the nucleus.
Network arrangement and remodeling
In simple terms: The cell arranges and rearranges the filament network as needed.
Once assembled, IF networks are arranged into cell-type-specific patterns that can be remodeled in response to signals, mechanical stress, or developmental cues. This remodeling includes changes in filament density, bundling, and interactions with other cytoskeletal systems, forming a complex interacting meshwork. In mesenchymal cells, vimentin IFs act as structural and mechanical coordinators that influence cell behavior.
Disassembly and turnover
In simple terms: Cells can also take apart intermediate filaments when they need to reorganize.
Disassembly and turnover of IF networks are part of normal cytoskeletal dynamics and are required for processes such as mitosis, migration, and differentiation. The balance between assembly and disassembly helps cells adapt their mechanical properties and architecture. Defects in these processes can lead to abnormal IF aggregation or loss of network integrity.
Interaction with associated proteins
In simple terms: Other proteins bind to intermediate filaments and help organize them.
IF organization involves associated proteins that regulate filament bundling, crosslinking, and linkage to other cellular structures. These interactions contribute to the functional diversity of IF networks across cell types. For example, glial intermediate filament aggregation can be induced by loss of sacsin, highlighting the role of associated factors in network organization.
Key Genes Involved in GO:0045104 intermediate filament cytoskeleton organization
The following genes and proteins are representative components or regulators of intermediate filament cytoskeleton organization (GO:0045104).
| Gene | Major Role | Research Relevance |
|---|---|---|
| KRT5 | Keratin 5, basal epithelial IF protein | Skin blistering disorders; epithelial organization |
| KRT14 | Keratin 14, basal epithelial IF protein | Epidermolysis bullosa; keratin network assembly |
| VIM | Vimentin, mesenchymal IF protein | Cell migration, mechanotransduction, cancer biology |
| DES | Desmin, muscle IF protein | Muscle integrity; desmin-related myopathies |
| GFAP | Glial fibrillary acidic protein | Astrocyte organization; neurodegeneration |
| NEFL | Neurofilament light chain | Axonal structure; neurodegenerative disease |
| NEFM | Neurofilament medium chain | Neurofilament assembly; axonal caliber |
| NEFH | Neurofilament heavy chain | Neurofilament network; neurodegeneration |
| LMNA | Lamin A/C, nuclear IF protein | Nuclear envelope organization; laminopathies |
| LMNB1 | Lamin B1, nuclear IF protein | Nuclear organization; development |
| SACS | Sacsin, regulator of IF organization | Glial IF aggregation; neurodegeneration |
| CRNN | Cornulin, epithelial IF-associated protein | Epithelial differentiation |
| PRPH | Peripherin, neuronal IF protein | Peripheral nerve organization |
| INA | Alpha-internexin, neuronal IF protein | Neurofilament network assembly |
| KRT8 | Keratin 8, simple epithelial IF protein | Epithelial organization; liver disease |
| KRT18 | Keratin 18, simple epithelial IF protein | Epithelial organization; cancer biology |
| PLEC | Plectin, IF crosslinking protein | Cytoskeletal linkage; skin and muscle disorders |
How Is intermediate filament cytoskeleton organization Regulated?
Intermediate filament cytoskeleton organization is regulated at multiple levels, including gene expression, post-translational modification, and interaction with associated proteins. The dynamic nature of IF networks allows cells to respond to mechanical and biochemical signals by altering filament assembly and arrangement. In disease contexts, abnormal regulation can lead to IF aggregation, as seen when sacsin deletion induces glial intermediate filament aggregation. Additionally, vimentin IFs can act as mechanical coordinators in mesenchymal cells, integrating signals that affect cell behavior.
intermediate filament cytoskeleton organization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NEFL | Neurodegeneration; axonal dysfunction | Knockout or point-mutation in neuronal cell lines |
| GFAP | Glial IF aggregation; neurodegeneration | Knockout or overexpression in astrocytes |
| KRT5 | Epidermolysis bullosa; skin blistering | Knock-in of patient mutations in keratinocytes |
| VIM | Cancer progression; cell migration | Knockout or overexpression in mesenchymal cells |
| SACS | Neurodegeneration; glial IF aggregation | Knockout in glial cell models |
Neurodegeneration and neurofilament organization
Neurofilaments are neuronal intermediate filaments that are essential for axonal structure and function, and their organization is disrupted in several neurodegenerative diseases. Abnormal accumulation or misorganization of neurofilaments is a pathological feature in conditions such as amyotrophic lateral sclerosis and other neuropathies. Loss of sacsin, a protein linked to neurodegenerative disease, induces aggregation of glial intermediate filaments, further supporting the link between IF organization and neuronal health.
Skin and epithelial disorders
Keratins are intermediate filament proteins in epithelial cells, and mutations in keratin genes can cause skin blistering disorders due to defective keratin network organization. These disorders highlight the importance of intermediate filament cytoskeleton organization for tissue integrity and mechanical resilience. Research into keratin assembly and disassembly continues to inform therapeutic strategies for these conditions.
Cancer and vimentin intermediate filaments
Vimentin intermediate filaments are expressed in mesenchymal cells and are often upregulated in cancer, where they contribute to cell migration, invasion, and mechanical properties. Vimentin IFs act as structural and mechanical coordinators of mesenchymal cells, influencing tumor progression and metastasis. Understanding how vimentin networks are organized may provide opportunities for therapeutic intervention.
From intermediate filament cytoskeleton organization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of an IF gene disrupt network organization? | CRISPR knockout cell line |
| Does a disease-associated point mutation alter IF assembly? | CRISPR point-mutation knock-in |
| Can a tagged IF protein track network dynamics? | Tagged knock-in (e.g., GFP) cell line |
| Does overexpression of an IF protein cause aggregation? | CRISPR overexpression cell model |
| Which genes regulate IF organization? | CRISPR library screening |
| What pathways are altered by IF network disruption? | Transcriptomics and bioinformatics |
How to Study the intermediate filament cytoskeleton organization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | IF network morphology and dynamics | Visualizing assembly and disassembly |
| Live-cell imaging | Real-time filament remodeling | Tracking IF dynamics under stress |
| Proteomics | IF-associated proteins and modifications | Defining IF interactome |
| RNA-seq | Expression of IF genes and pathways | Linking IF organization to cell states |
| CRISPR knockout | Loss-of-function effects on IF networks | Testing causal roles of IF genes |
| CRISPR knock-in | Effects of specific mutations | Modeling disease-associated variants |
| CRISPR overexpression | Gain-of-function effects | Studying IF aggregation and toxicity |
| CRISPR library screening | Unbiased discovery of regulators | Identifying novel IF organization genes |
Fluorescence imaging of IF networks
Fluorescence microscopy, including live-cell imaging, is widely used to visualize intermediate filament organization and dynamics. Tagged IF proteins or specific antibodies allow researchers to monitor filament assembly, arrangement, and disassembly in real time. This approach is essential for assessing how genetic perturbations affect IF networks.
Proteomics and interactomics
Proteomic approaches can identify IF-associated proteins and post-translational modifications that regulate network organization. Mass spectrometry-based interactomics helps define the composition of IF protein complexes in different cell types. These methods complement imaging by providing molecular details of IF regulation.
Transcriptomics and bioinformatics
RNA sequencing and bioinformatics analyses can reveal changes in IF gene expression and related pathways under different conditions. Such studies help link IF organization to broader cellular programs, including differentiation and stress responses. Integrating transcriptomic data with imaging and proteomics provides a systems-level view of IF biology.
CRISPR-based functional assays
CRISPR knockout, knock-in, and overexpression models enable causal testing of IF genes in relevant cell types. These models can be combined with imaging and biochemical assays to determine how specific mutations affect IF organization. Library screening approaches allow unbiased discovery of regulators of IF networks.
How CRISPR Can Be Used to Study GO:0045104 intermediate filament cytoskeleton organization
Knockout
CRISPR knockout of intermediate filament genes can reveal their requirement for network organization and cell function. For example, knocking out vimentin or neurofilament genes in relevant cell types allows researchers to assess changes in filament assembly and mechanical properties. Knockout models are also useful for validating findings from library screens.
Point Mutation
CRISPR point-mutation knock-in can model disease-associated variants in IF genes, such as those found in keratin disorders or neurofilamentopathies. These models help determine whether a specific mutation alters filament assembly, network arrangement, or interactions with associated proteins. Point-mutation models are valuable for precision medicine research.
Knock-in
Tagged knock-in of IF genes, such as GFP or epitope tags, enables real-time tracking of filament dynamics and localization. Knock-in of regulatory elements or reporters can also help study IF gene expression in specific cell types. These models are essential for understanding how IF networks are organized in living cells.
Overexpression
CRISPR-mediated overexpression of IF proteins can model gain-of-function effects, including filament aggregation and toxicity. Overexpression models are particularly useful for studying diseases where IF protein accumulation is a hallmark, such as neurodegeneration. They can also be used to test whether increased IF levels alter cell migration or mechanical properties.
How EDITGENE Supports intermediate filament cytoskeleton organization Research
Researchers studying intermediate filament cytoskeleton organization-related genes often need to determine whether a candidate gene is causally involved in filament assembly, network arrangement, or disassembly. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbations to test these hypotheses in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for intermediate filament cytoskeleton organization research.
Frequently Asked Questions About intermediate filament cytoskeleton organization
What is GO:0045104 intermediate filament cytoskeleton organization?
GO:0045104 is a biological process that describes the assembly, arrangement, and disassembly of intermediate filament networks and their associated proteins.
What genes are involved in intermediate filament cytoskeleton organization?
Key genes include KRT5, KRT14, VIM, DES, GFAP, NEFL, NEFM, NEFH, LMNA, and SACS, among others.
Why is intermediate filament organization important?
It maintains cell shape and mechanical integrity, supports tissue function, and its disruption is linked to neurodegeneration, skin disorders, and cancer.
How is intermediate filament organization studied?
Researchers use fluorescence imaging, proteomics, transcriptomics, and CRISPR-based models to study IF organization.
What diseases are associated with intermediate filament organization?
Neurodegenerative diseases, skin blistering disorders, and cancer are associated with disrupted IF organization.
What is the role of vimentin in intermediate filament organization?
Vimentin forms IF networks in mesenchymal cells and acts as a structural and mechanical coordinator.
How do CRISPR knockouts help study intermediate filament organization?
CRISPR knockouts remove specific IF genes to test their requirement for network assembly and cell function.
Can point mutations in IF genes be modeled with CRISPR?
Yes, CRISPR point-mutation knock-in can model disease-associated variants in IF genes.
What is the relationship between neurofilaments and neurodegeneration?
Neurofilament organization is critical for axonal function, and its disruption is a feature of several neurodegenerative diseases.
What services does EDITGENE offer for IF research?
EDITGENE provides knockout, point-mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics services.
Conclusion
Intermediate filament cytoskeleton organization (GO:0045104) is a fundamental cellular process that governs the assembly, arrangement, and disassembly of IF networks and their associated proteins. Its importance spans basic cell biology, tissue mechanics, and human disease, with strong links to neurodegeneration, skin disorders, and cancer. Continued research using advanced imaging, omics, and CRISPR-based models will further clarify how IF networks are regulated and how their dysfunction contributes to pathology.
References
- 1. Hohmann T et al.. 2019. The Cytoskeleton-A Complex Interacting Meshwork.. Cells 8(4) PMID: 31003495
- 2. Coulombe PA. 2022. Capturing intermediate filament networks.. Elife 11 PMID: 35377313
- 3. Eriksson JE et al.. 1992. Intermediate filament dynamics.. Curr Opin Cell Biol 4(1):99-104 PMID: 1558758
- 4. Yuan A et al.. 2017. Neurofilaments and Neurofilament Proteins in Health and Disease.. Cold Spring Harb Perspect Biol 9(4) PMID: 28373358
- 6. Murtinheira F et al.. 2022. Sacsin Deletion Induces Aggregation of Glial Intermediate Filaments.. Cells 11(2) PMID: 35053415
- 7. Parry DA et al.. 1992. Intermediate filament structure.. Curr Opin Cell Biol 4(1):94-8 PMID: 1373068
- 8. Guo M et al.. 2025. Vimentin intermediate filaments as structural and mechanical coordinators of mesenchymal cells.. Nat Cell Biol 27(8):1210-1218 PMID: 40764390
